Owens & Minor Inc (OMI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Owens & Minor Inc (OMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9969
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products’ manufacturers, and the federal government. It has operations in North America and Europe. Owens & Minor is headquartered in Richmond, Virginia, the US.

Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Owens & Minor Inc, Medical Devices Deals, 2012 to YTD 2018 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Acquisition 15
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc – Key Competitors 18
Owens & Minor Inc – Key Employees 19
Owens & Minor Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 24
Financial Announcements 24
Aug 07, 2018: Owens & Minor reports financial results for 2nd quarter 2018 24
Feb 14, 2018: Owens & Minor Reports 4th Quarter & Full-Year 2017 Financial Results 26
Jan 31, 2018: Owens & Minor Previews 2017 Preliminary Financial Results 28
Nov 01, 2017: Owens & Minor Reports 3rd Quarter 2017 Financial Results 29
Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 31
May 02, 2017: Owens & Minor Reports 1st Quarter 2017 Financial Results 33
Mar 16, 2017: Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018 at Annual Investor Meeting 34
Feb 14, 2017: Owens & Minor Reports 4th Quarter & Full-Year 2016 Financial Results 35
Corporate Communications 37
Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions 37
Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer 38
Mar 27, 2018: Owens & Minor Appoints Shana Neal as SVP & Chief Human Resources Officer 39
Feb 28, 2018: Owens & Minor Names Dominion Energy Executive, Mark McGettrick, to its Board of Directors 40
Mar 13, 2017: Owens & Minor Welcomes New EVP of Global Manufacturer Services 41
Feb 10, 2017: Owens & Minor Announces That Healthcare Executive Barbara B. Hill Has Been Elected to Its Board of Directors 42
Feb 10, 2017: Craig R. Smith, Chairman of the Owens & Minor Board of Directors, Announces His Retirement 43
Government and Public Interest 44
Feb 27, 2018: Fusion5 Announces Formation to Meet Provider Needs in Value-Based Healthcare Models Including CMS’ BPCI Advanced Initiative 44
Other Significant Developments 45
Oct 23, 2017: Healthier Communities 20/20: A Clear Vision for Our Future; Owens & Minor will Explore this Theme at its 12th Annual Healthcare Supplier Diversity Symposium 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Owens & Minor Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Owens & Minor Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Owens & Minor Inc, Medical Devices Deals, 2012 to YTD 2018 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc, Key Competitors 18
Owens & Minor Inc, Key Employees 19
Owens & Minor Inc, Other Locations 21
Owens & Minor Inc, Subsidiaries 22

List of Figures
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Owens & Minor Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Owens & Minor Inc (OMI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pets at Home Limited (PETS):企業の財務・戦略的SWOT分析
    Pets at Home Limited (PETS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SSP Group Ltd:企業の戦略・SWOT・財務分析
    SSP Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SSP Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AF AB (AF B)-エネルギー分野:企業M&A・提携分析
    Summary AF AB is an engineering and consulting company. It offers various services such as product development and IT support to sectors including automotive, telecom, defense and life sciences. The company also provides services such as communications systems management, development of customized b …
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Reply SpA (REY):企業の財務・戦略的SWOT分析
    Reply SpA (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Petrofac Ltd (PFC):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrofac Limited (Petrofac) is an oilfield services company that provides integrated services to production and processing industries. It designs and builds oil and gas facilities; operates, maintains and manages facilities on behalf of its customers and trains personnel. It also develops an …
  • Experian plc:企業の戦略・SWOT・財務分析
    Experian plc - Strategy, SWOT and Corporate Finance Report Summary Experian plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nigeria LNG Ltd:企業の戦略的SWOT分析
    Nigeria LNG Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Polenergia SA (PEP):企業の財務・戦略的SWOT分析
    Polenergia SA (PEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • OMV Petrom SA (SNP):電力:M&Aディール及び事業提携情報
    Summary OMV Petrom SA (Petrom), a subsidiary of OMV AG, is an integrated energy company that explores for, develops and produces crude oil and natural gas. The company processes and refines crude oil and sells refined products. It conducts power generation and has considerable wind energy operations …
  • Sempra Energy (SRE):企業の財務・戦略的SWOT分析
    Sempra Energy (SRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Exosomics Siena SpA:企業の製品パイプライン分析2018
    Summary Exosomics Siena SpA (Exosomics Siena) is a biotechnology company that offers research and development services. The company provides services such as contract research, collaborative project management, lead development and technological services. It offers technological services such as sam …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Top Glove Corporation Berhad (TOPGLOV):医療機器:M&Aディール及び事業提携情報
    Summary Top Glove Corporation Berhad (Top Glove) is a manufacturer and distributor of rubber gloves. The company’s products include nitrile gloves, vinyl gloves, latex gloves, surgical gloves, clean room gloves, household gloves, polyisoprene gloves, and cast polyethylene gloves. It also provides th …
  • Platinum Group Metals Ltd (PTM):企業の財務・戦略的SWOT分析
    Platinum Group Metals Ltd (PTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Morphogenesis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphogenesis Inc (Morphogenesis) is a developer of novel cell and gene therapies to detect, monitor and control cancer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibod …
  • Foxconn Technology Co Ltd:企業の戦略・SWOT・財務分析
    Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ImmunoCellular Therapeutics Ltd (IMUC)-医療機器分野:企業M&A・提携分析
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆